Gehring; Doris

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gehring; Doris.The latest application filed is for "substituted diazahetero-bicyclic compounds and their use".

Company Profile

8.4.9

Gehring; Doris - Kelkheim DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted Diazahetero-bicyclic Compounds And Their Use App 20220259228 - DELBECK; Martina ; et al.	2022-08-18
Diazabicyclic Substituted Imidazopyrimidines And Their Use For The Treatment Of Breathing Disorders App 20220017540 - DELBECK; Martina ; et al.	2022-01-20
Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitors Grant 11,208,422 - Delbeck , et al. December 28, 2	2021-12-28
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders Grant 11,098,063 - Delbeck , et al. August 24, 2	2021-08-24
Substituted Diazahetero-bicyclic Compounds And Their Use App 20210024545 - DELBECK; Martina ; et al.	2021-01-28
2-phenyl-3-(piperazinomethyl)imidazo[1,2-A]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders Grant 10,759,794 - Delbeck , et al. Sep	2020-09-01
Substituted Bridged Diazepane Derivatives And Use Thereof As Task-1 And Task-3 Inhibitors App 20200140461 - DELBECK; Martina ; et al.	2020-05-07
Diazabicyclic Substituted Imidazopyrimidines And Their Use For The Treatment Of Breathing Disorders App 20200109155 - DELBECK; Martina ; et al.	2020-04-09
Pharmaceutical Dosage Forms Containing Task-1 And Task-3 Channel Inhibitors, And The Use Of Same In Breathing Disorder Therapy App 20200093737 - ANLAHR; Johanna ; et al.	2020-03-26
Pharmaceutical Dosage Forms Containing Task-i And Task-3 Channel Inhibitors, And The Use Of Same In Breathing Disorder Therapy App 20200085734 - ANLAHR; Johanna ; et al.	2020-03-19
Substituted perhydropyrrolo[3,4-c]pyrrole derivatives and the use of same Grant 10,414,765 - Delbeck , et al. Sept	2019-09-17
2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine Derivatives As Blockers Of Task-1 And Task-2 Channels, For The Treatment Of Sleep-related Breathing Disorders App 20190062326 - DELBECK; Martina ; et al.	2019-02-28
Substituted Perhydropyrrolo[3,4-c]pyrrole Derivatives And The Use Of Same App 20180370965 - DELBECK; Martina ; et al.	2018-12-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.